4月24日，2026年中美青年卫生健康对话（长沙站）在中南大学湘雅医学院举行。湖南省委书记沈晓明出席并致辞。活动中，美国国家医学院和工程院两院院士，美国发明家学院院士，南加州大学生物医学治疗学院院长，南加大Roski眼科学院联合院长，我司医学技术总负责人、联合创始人，董事会成员马克院士，特邀作《视网膜疾病与视网膜植入假体——脑机接口应用》主题演讲。
报告中，马克院士详细介绍了公司核心产品——侵入式脑机接口“IMIE智能视网膜”的项目原理、核心技术优势与应用场景，并宣布该项目近日已在湘雅医院成功完成首例临床应用手术，成为医工、科创深度融合的重要里程碑。他表示，微智将架设中外医学科技技术交流的桥梁，让侵入式脑机接口技术普惠全球患者。
2026年中美青年卫生健康对话在长沙举行 沈晓明致辞
The 2026 China-US Youth Health Dialogue was held in Changsha
Hunan Provincial Party Secretary Shen Xiaoming delivered a speech
Mark Humayun, Co-founder of IntelliMicro and Member of the US National Academy of Medicine and the U.S. National Academy of Engineering gave a keynote speech
On April 24,the 2026 China-US Youth Health Dialogue (Changsha Session) was held at Xiangya School of Medicine, Central South University. Hunan Provincial Party Secretary Shen Xiaoming attended the event and delivered a speech.
During the event, Academician Mark, Member of the US National Academy of Medicine and the U.S. National Academy of Engineering, Member of the U.S. National Academy of Inventors, Dean of the School of Biomedical Therapy at the University of Southern California(USC), the Co-Dean of the Roski Eye Institute at the USC, Chief Medical Technology Officer and Co-founder and Board Member of IntelliMicro, was specially invited to give a keynote speech on "Retinal Diseases and Retinal Implants - BCI Applications".
In his report, Academician Mark detailed the project principles, core technological advantages, and application scenarios of the Company's core product—the invasive BCI "IMIE Intelligent Retina." He also announced that the project recently completed its first clinical application surgery at Xiangya Hospital, marking a significant milestone in the deep integration of medicine and engineering. He stated that IntelliMicro will build a bridge for medical technology exchanges between China and other countries, making invasive BCI technology accessible to patients worldwide.
2026年中美青年卫生健康对话在长沙举行 沈晓明致辞
